Articles by Stefan Engeli

New developments in the pathogenesis of obesity-induced hypertension

Kotsis, Vasilios; Nilsson, Peter; Grassi, Guido; More

Journal of Hypertension. 33(8):1499-1508, August 2015.

Differential response of the natriuretic peptide system to weight loss and exercise in overweight or obese patients

Haufe, Sven; Kaminski, Jana; Utz, Wolfgang; More

Journal of Hypertension. 33(7):1458-1464, July 2015.

Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and early vascular ageing

Jordan, Jens; Nilsson, Peter M.; Kotsis, Vasilios; More

Journal of Hypertension. 33(3):425-434, March 2015.

Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension

Jordan, Jens; Yumuk, Volkan; Schlaich, Markus; More

Journal of Hypertension. 30(6):1047-1055, June 2012.

European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes

Jordan, Jens; Schlaich, Markus; Redon, Josep; More

Journal of Hypertension. 29(2):189-193, February 2011.

Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-γ activation

Janke, Jürgen; Schupp, Michael; Engeli, Stefan; More

Journal of Hypertension. 24(9):1809-1816, September 2006.